Global Single Use Bioprocessing Market

Global Single Use Bioprocessing Market Size, Share, Growth Analysis, By Workflow(Upstream, Downstream), By Product(Filtration Assembles, Disposable Bioreactors), By End-User(Biopharmaceutical Manufacturers, Clinical & Academic Research Institutes) - Industry Forecast 2024-2031

Report ID: SQMIG35I2263 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 91 | Figures: 76

Global Single Use Bioprocessing Market News

  • In March 2022, High Purity New England announced the launch of its new manufacturing facility with the investment of USD 10 million. The new facility will serve as the company’s specialty manufacturing and distribution center and help the company to increase its manufacturing capacity and fulfill the consumer rising needs.
  • In March 2022, Central Research Laboratories launched the latest single-use Beta Bag product line in its wide range of product offerings with advanced technology. These beta bags are indispensable components in various applications including waste handling and ready-to-use component transfer facilities.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Single Use Bioprocessing Market size was valued at USD 8.2 billion in 2019 and is poised to grow from USD 9.88 billion in 2023 to USD 52.93 billion by 2031, growing at a CAGR of 20.5% in the forecast period (2024-2031).

The global single use bioprocessing market is moderately competitive with the presence of many international and regional market players operating all over the world. The top 5 companies of the market dominated the majority of market share including Thermo Fisher Scientific, Sartorius AG, and Eppendorf AG. Key players are implementing on several business strategies including new innovation, acquisition, mergers, partnerships, and collaboration for the expansion of their geographical presence and product portfolio. 'Thermo Fisher Scientific, Inc.', 'Sartorius AG', 'Merck KGaA', 'GE Healthcare Life Sciences', 'Pall Corporation (a Danaher Company)', 'Parker Hannifin Corporation', 'Eppendorf AG', '3M Company', 'Meissner Filtration Products, Inc.', 'Entegris, Inc.', 'Repligen Corporation', 'Saint-Gobain Performance Plastics Corporation', 'Finesse Solutions, Inc. (a part of Thermo Fisher Scientific, Inc.)', 'ATMI LifeSciences (a part of Entegris, Inc.)', 'Applikon Biotechnology BV', 'PendoTECH', 'Corning, Inc.', 'Cesco Bioengineering Co., Ltd.', 'Fujifilm Irvine Scientific', 'Abec, Inc.'

The growing global aging population is expected to drive the global single use bioprocessing market during the forecast period. According to a report by UN ageing population highlights, approximately 727 million people in the global population were aged 65 and over in 2020, with the figure expected to rise to nearly 1.5 billion by 2050. With the significant increase in the number of elderly people, the demand for biopharmaceuticals is expected to rise significantly, as is the increasing focus and preference of major corporations on the improvement of efficiency and cost reduction of single-use systems.

Increasing number of innovations coupled with the rising prevalence of advanced technology and rapid investing in research & development are likely to create lucrative opportunities for the global single use bioprocessing market in the coming years. Furthermore, rising number of company activities in developing single use disposable systems is also contributing to the growth and demand for the market. For instance, in March 2021, Thermo Fisher Scientific launched its new 3,000 L and 5,000 L HyPerforma single use bioreactors.

Globally, North America dominated the single use bioprocessing market and accounted for a healthy market share in 2021 and is expected to maintain its dominance throughout the forecast period. The rising biopharmaceutical research & development activities and large presence of international market players such as Thermo Fisher Scientific Inc., Danaher Corporation, and G&G Technologies in the region are the major factors projected to drive the growth of the market over the coming years. For instance, in January 2021, Fujifilm Diosynth invested an amount of USD 2 billion in its United States sites for the expansion of its cell culture production in the country.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Single Use Bioprocessing Market

Report ID: SQMIG35I2266 | Region: Global | Published Date: February, 2024 | Pages: 219 | Tables: 89 | Figures: 76

Global Human Insulin Market
Buy Now GET FREE SAMPLE
Global Single Use Bioprocessing Market

Report ID: UCMIG35I2118 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Psoriasis Drugs Market
Buy Now GET FREE SAMPLE
Global Single Use Bioprocessing Market

Report ID: UCMIG35I2184 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Narcolepsy Therapeutics Market
Buy Now GET FREE SAMPLE
Global Single Use Bioprocessing Market

Report ID: UCMIR35I2211 | Region: Regional | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

MEA Parenteral Nutrition Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Single Use Bioprocessing Market

Product ID: SQMIG35I2263

$5,300
BUY NOW GET FREE SAMPLE